Qiagen NV | QIA - 债务

金融业

USD

USD 5.78B

现金及等价物

USD 646.29M

USD 182.72M

USD 1.54B

USD 479.11M

USD 1.65B

股息收益率

USD 0.63

USD 96.88M

USD 207.66M

USD 6.18K

EPS每股收益

USD 0.54

股本和储备

USD 3.33B

USD 309.6M

债务利息支出

USD 11.05M

USD 10.56M

USD 1.65B

USD 8.06B

USD 68.04M

USD 375.69M

USD 116.63M

普通股股本

USD 206.25M

19.48

USD 85.83M

USD 463.12M

销售和管理费用

USD 142.39M

USD 309.61M

贸易债权人

USD 78.3M

应收帐款人

USD 396.62M

	债务	更改		日
Akebia Therapeutics	USD 46.51M		7.82M	2025-03
Alaunos Therapeutics	USD 10.99M		5.78M	2023-03
argenx SE	USD 47.16M		4.01M	2025-12
Avita Medical	AUD 46.05M		1.46M	2025-12
Dianthus Therapeutics	USD 1.36M		79K	2026-03
Ionis Pharmaceuticals	USD 1.91B		425.5M	2026-06
IQVIA Holdings	USD 16.24B		408M	2026-06
Moderna	USD 1.3B		7M	2026-03
Organon & Co	USD 8.57B		75M	2026-03
Qiagen NV	USD 1.65B		165.82M	2026-03
Revvity	USD 3.35B		48.03M	2026-03
Tectonic Therapeutic	USD 876K		115K	2024-12
Viatris	USD 13.35B		993.3M	2026-06
Xeris Pharmaceuticals	USD 258.55M		899K	2026-03